The article discusses the use of the gene editing technique CRISPR/Cas9 to increase dystrophin as a way to treat dogs with duchenne muscular dystrophy, referencing a study coauthored by molecular biologist Eric Olson in the "Science" journal.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados